Evaluation of CellerateRX Surgical Powder utility in reducing groin complications after femoral exposure

Vascular procedures involving groin incisions for femoral exposure often have complications that delay wound healing. These complications include but are not limited to the development of seromas, hematomas, skin necrosis, or infection requiring reintervention leading to readmission, increased length of stay, and increased morbidity and mortality, including limb loss. In this non-concurrent cohort study, we evaluate the usefulness of CellerateRX Surgical Powder in preventing postoperative groin complications. We compare the outcomes of groin incisions that received standard surgical wound care and those in which CellerateRX Surgical Powder was applied to the surgical incision prior to primary closure. Groin incisions required for femoral exposure in vascular surgery procedures were considered. The control group included cases between 2020 and 2021. Exclusion criteria included patients